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The Gram-negative bacteriumVerrucomicrobium spinosum has attracted interest in recent
years following the sequencing and annotation of its genome. Comparative genomic
analysis ofV. spinosum using diaminopimelate/lysine metabolic genes from Chlamydia tra-
chomatis suggests that V. spinosum employs the L,L-diaminopimelate aminotransferase
(DapL) pathway for diaminopimelate/lysine biosynthesis. The open reading frame corre-
sponding to the putative dapL ortholog was cloned and the recombinant enzyme was
shown to possess L,L-diaminopimelate aminotransferase activity in vitro. In vivo analysis
using functional complementation conﬁrmed that the dapL ortholog was able to func-
tionally complement an E. coli mutant that confers auxotrophy for diaminopimelate and
lysine. In addition to its role in lysine biosynthesis, the intermediate diaminopimelate has an
integral role in peptidoglycan biosynthesis. To this end, the UDP-N -acetylmuramoylalanyl-
D-glutamyl-2,6-meso-diaminopimelate ligase ortholog was also identiﬁed, cloned, and was
shown to possess meso-diaminopimelate ligase activity in vivo. The L,L-diaminopimelate
aminotransferase pathway has been experimentally conﬁrmed in several bacteria, some
of which are deemed pathogenic to animals. Since animals, and particularly humans, lack
the genetic machinery for the synthesis of diaminopimelate/lysine de novo, the enzymes
involved in this pathway are attractive targets for development of antibiotics.Whether dapL
is an essential gene in any bacteria is currently not known.V. spinosum is an excellent candi-
date to investigate the essentiality of dapL, since the bacterium employs the DapL pathway
for lysine and cell wall biosynthesis, is non-pathogenic to humans, facile to grow, and can
be genetically manipulated.
Keywords: lysine, diaminopimelate,L,L-diaminopimelate aminotransferase, peptidoglycan, functional complemen-
tation
INTRODUCTION
Verrucomicrobium spinosum is a rod-shaped heterotrophic Gram-
negative bacterium that is found in fresh water and soil envi-
ronments and is characterized as being non-motile and contains
appendages known as prosthecae. V. spinosum is important to
the biotechnology and medical sectors as it is closely related
to Chlamydia (Wagner and Horn, 2006). A recent study con-
ﬁrmed that the organism contains all the genetic components to
encode a Type III Secretion System and was able to kill Drosophila
melanogaster and Caenorhabditis elegans, two model invertebrate
hosts (Sait et al., 2011).
Genomic analysis of V. spinousm show that the organ-
ism contains all the genes necessary for the synthesis of
diaminopimelate/lysine de novo and thus the bacterium is pro-
totrophic for lysine. Lysine is synthesized using two general
pathways that are evolutionarily divergent with respect to the
intermediates used. One pathway utilizes the intermediate α-
amino adipic acid, which is derived from the metabolism of
2-ketoglutarate a product of the citric acid cycle. The α-amino
adipic acid pathway is primarily used by fungi and is narrowly
distributed to a few species belonging to the domain archaea
(Nishida et al., 1999; Velasco et al., 2002). The other pathway
employs the intermediate diaminopimelate, which is derived from
oxaloacetate. The diaminopimelate pathway is found in most bac-
teria andphotosynthetic organisms including cyanobacteria, algae,
and plants.
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Four variants of the diaminopimelate/lysine pathway have
been discovered so far (Figure 1): the two acyl pathways,
which use either succinyl or acetyl intermediates; the meso-
diaminopimelate dehydrogenase pathway; and the recently dis-
covered L,L-diaminopimelate aminotransferasae (DapL) pathway
(Hudson et al., 2006, 2008; McCoy et al., 2006). The biosyn-
thesis of lysine from aspartate via the diaminopimelate/lysine
pathway can be divided into three main events. The ﬁrst event
is the synthesis of tetrahydrodipicolinate from aspartate. This is
a general feature of all four diaminopimelate pathway variants
and is carried out by the enzymes, aspartate kinase, aspartate
semialdehyde dehydrogenase, dihydrodipicolinate synthase, and
dihydrodipicolinate reductase, respectively (Table 1). The sec-
ond event constitutes the conversion of tetrahydrodipicolinate
to the penultimate intermediate meso-diaminopimelate. The syn-
thetic steps from tetrahydrodipicolinate to meso-diaminopimelate
deﬁne the uniqueness of the diaminopimelate variant pathways.
In the acyl pathways, four enzymes are required. These reactions
are carried out by the enzymes 2,3,4,5-tetrahydropyridine-2,6-
dicarboxylate N -acyl-transferase, acyl-diaminopimelate amino-
transferase, acyl-diaminopimelate deacylase, and diaminopime-
late epimerase, respectively (Table 1, Figure 1). In the dehy-
drogenase pathway, tetrahydrodipicolinate is converted to meso-
diaminopimelate by the enzyme meso-diaminopimelate dehydro-
genase in one step circumventing the 2,3,4,5-tetrahydropyridine-
2,6-dicarboxylate-acyl-transferase, acyl-diaminopimelate amino-
transferase, acyl-diaminopimelate deacylase, and diaminopime-
late epimerase enzymatic reactions (Table 1, Figure 1). The L,L-
diaminopimelate aminotransferase (DapL) pathway synthesizes
L,L-diaminopimelate from tetrahydrodipicolinate by a transam-
ination reaction using glutamate as the amino donor and
tetrahydrodipicolinate as the amino acceptor in a single reac-
tion bypassing the 2,3,4,5-tetrahydropyridine-2,6-dicarboxylate
-acyl-transferase, acyl-diaminopimelate aminotransferase, acyl-
diaminopimelate deacylase steps present in the succinylated or
acetylated diaminopimelate/lysine pathways (Table 1, Figure 1).
The third and ultimate event in the diaminopimelate variant path-
ways is deﬁned by the enzyme meso-diaminopimelate decarboxy-
lase which catalyzes the decarboxylation of meso-diaminopimelate
to synthesize lysine. This decarboxylation step is shared by all four
variants (Table 1, Figure 1).
Since animals do not contain the machinery to synthesize
diaminopimelate or lysine, which are used by bacteria for pep-
tidoglycan biosynthesis, the enzymes involved in the bacterial
diaminopimelate/lysine biosynthesis pathways are of interest to
the scientiﬁc community. meso-Diaminopimelate serves as one
of the cross linking amino acids in the cell wall of Gram-
negative bacteria, whereas lysine has the same role in Gram-
positive bacteria (Hutton et al., 2007). Inhibition of enzymes
in the diaminopimelate/lysine biosynthesis pathways would have
a detrimental effect to bacterial growth from two perspectives:
since diaminopimelate is necessary for cell wall synthesis, cell lysis
will occur as a result of osmotic pressure from the lack of pep-
tidoglycan (Cox, 1996; Baizman et al., 2000); in addition, the
inhibition of enzymes in the pathway will prevent protein syn-
thesis, since lysine is one of the 20 common proteogenic amino
acids. meso-Diaminopimelate is incorporated as one of the cross
linking amino acids in the cell wall of Gram-negative bacteria
FIGURE 1 | Diaminopimelate/lysine biosynthesis pathways.The four
variants of the diaminopimelate/lysine biosynthetic pathways starting from
tetrahydrodipicolinate are denoted as (A) the succinylated or acetylated
pathways, (B) the meso-diaminopimelate dehydrogenase pathway, and (C) the
L,L-diaminopimelate aminotransferase (DapL) pathway. The abbreviations of
the enzymes along with the enzyme reaction deﬁnitions are listed inTable 1.
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Table 1 | List of diaminopimelate/lysine biosynthesis genes fromV. spinosum DSM 4136T.
Locus tag Gene symbol Gene name EC # Reaction definition
VspiD_010100025585 lysC Aspartate kinase 2.7.2.4 ATP+aspartate↔ADP+4-phospho-aspartate
VspiD_010100030480 asd Aspartate semialdehyde
dehydrogenase
1.2.1.11 aspartate 4-semialdehyde+orthophosphate+NADP+ ↔4-
phospho-L-aspartate+NADPH+H+
VspiD_010100011370 dapA Dihydrodipicolinate
synthase
4.2.1.52 Aspartate 4-semialdehyde+pyruvate↔L-2,3-
dihydrodipicolinate+2H2O
VspiD_010100011365 dapB Dihydrodipicolinate
reductase
1.3.1.26 2,3,4,5-Tetrahydrodipicolinate+NADP+↔L-2,3-
dihydrodipicolinate+NADPH+H+
- dapD 2,3,4,5-tetrahydropyridine-
2,6-dicarboxylate
Nacyl-transferase
2.3.1.117 Acyl-CoA+2,3,4,5-tetrahydrodipicolinate+H2O↔CoA+N -
acyl-2-L-amino-6-oxoheptanedioate
- dapC Acyl-diaminopimelate
aminotransferase
2.6.1.17 N -acyl-L,L-2,6-diaminoheptanedioate+2-oxoglutarate↔N -
acyl-2-L-amino-6-oxoheptanedioate+L-glutamate
- dapE Acyl-diaminopimelate
deacylase
3.5.1.18 N -acyl-L,L-2,6-diaminoheptanedioate+H2O↔ acyl+L,L-
2,6-diaminoheptanedioate
- ddh Diaminopimelate
dehydrogenase
1.4.1.16 meso-2,6-Diaminoheptanedioate+NADP+ +H2O↔L-2-
amino-6-oxoheptanedioate+NH3 +NADPH
VspiD_010100012510 dapL L,L-diaminopimelate
aminotransferase
2.6.1.83 L,L-2,6-diaminopimelate+2-oxoglutarate↔2,3,4,5-
tetrahydrodipicolinate+L-glutamate+H2O
VspiD_010100011375 dapF Diaminopimelate
epimerase
5.1.1.7 L,L-2,6-diaminopimelate↔meso-2,6-diaminopimelate
VspiD_010100003650 lysA Diaminopimelate
decarboxylase
4.1.1.20 meso-2,6-Diaminopimelate→lysine+CO2
The list was generated using the genomic information deposited in the IMG database (http://img.jgi.doe.gov/cgi-bin/w/main.cgi).
by the enzyme UDP-N -acetylmuramoylalanyl-d-glutamyl-2,6-
meso-diaminopimelate ligase (MurE) (E.C. 6.3.2.15), which is
encoded by the murE gene.
The DapL pathway has been identiﬁed in numerous bacteria
and been experimentally conﬁrmed in a limited number of bac-
teria, some of which are deemed pathogenic (McCoy et al., 2006;
Hudson et al., 2008; Liu et al., 2010). The three-dimensional crys-
tal structure of DapL from Arabidopsis thaliana has been solved
(Watanabe et al., 2007,2008) fromChlamydia trachomatis (Watan-
abe et al., 2011) and from the algae Chlamydomonas reinhardtii
(Dobson et al., 2011; Hudson et al., 2011a). Inhibitors for the Ara-
bidopsis DapL ortholog have been reported using in vitro studies
(Fan et al., 2010). It should be noted that although inhibitors
the Arabidopsis DapL have been found, it is not known if these
compounds inhibit other aminotransferases.
The identiﬁcation of dapL and murE genes, in addition to
the easy culturability and genetic manipulation of V. spinosum,
makes the bacterium an excellent model organism for experi-
ments addressing the essentiality of dapL and murE with respect
to lysine and peptidoglycan biosynthesis (Domman et al., 2011).
Most bacterial species that contain the DapL pathway are difﬁ-
cult to work with, since they are either slow growing, difﬁcult to
culture, anaerobic, and pathogenic to humans.
Here we present the ﬁrst genomic and biochemical analysis
of the diaminopimelate/lysine biosynthesis pathway from V. spin-
osum. We identify the genes necessary for diaminopimelate/lysine
biosynthesis in the genome of V. spinosum and demonstrate that
the bacterium uses the recently discovered DapL pathway for
diaminopimelate/lysine biosynthesis. In addition, we identify and
characterizeMurE fromV. spinosum, suggesting that the bacterium
incorporates meso-diaminopimelate into its peptidoglycan as a
cross linking amino acid.
RESULTS
IDENTIFICATION OF PUTATIVE dapL AND murE GENES IN V. SPINOSUM
The dapL ortholog from V. spinosum was identiﬁed using the
DapL protein from C. trachomatis Ct390 (NP_219900) as the
query with the BlastP algorithm from the Integrated Microbial
Genomes (IMG) database1. This search identiﬁed a putative L,L-
diaminopimelate aminotransferase annotated by the locus tag
VspiD_010100012510 (ZP_02927470) that is 38% amino acid
identity to the C. trachomatis DapL. The murE ortholog was iden-
tiﬁed using the C. trachomatis MurE (NP_219774) as a query. This
search resulted in the identiﬁcation of the murE ortholog from V.
spinosum annotated by the locus tag VspiD_010100019130, which
is 37% identical to the C. trachomatis MurE.
CRUDE SOLUBLE PROTEIN EXTRACT FROM V. SPINOSUM CONTAINS
DapL ACTIVITY
If V. spinosum utilizes the DapL pathway for diaminopime-
late/lysine biosynthesis, as suspected by the genomic analysis, a
crude soluble protein extract should possess DapL activity. The
ortho-aminobenzaldehyde assay was employed using a crude sol-
uble protein extract fromV. spinosum. Using L,L-diaminopimelate
1http://www.jgi.doe.gov/
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as the amino donor and 2-ketoglutarate as the amino accep-
tor, the assay measures the production of dihydroquinazolium
which is the product of the interaction between tetrahydrodipicol-
inate and ortho-aminobenzaldehyde. DapL activity was detected
from the crude soluble extract showing that the rate of the
reaction is proportional to the amount of V. spinosum pro-
tein extract added to the assay (Figure 2). Enzymatic activity
was not observed when the amino donor, or amino accep-
tor, was omitted from the assay. In addition, no activity was
observed when the protein extract was heated in boiling water
for 5 min.
DapL IS THE ONLY ROUTE FOR DIAMINOPIMELATE/LYSINE
BIOSYNTHESIS IN V. SPINOSUM
The genome of V. spinosum was searched to catalog the genes
necessary for the de novo anabolism of lysine from aspartate.
Since DapL activity was detected from a soluble extract, we
wanted to know whether the DapL pathway was the sole route
toward lysine biosynthesis. There are examples in the litera-
ture of multiple pathways for lysine biosynthesis in bacteria;
for example, the genomes of Bacteroides fragilis and Clostridium
thermocellum were found to contain both the DapL and meso-
diaminopimelate dehydrogenase pathways (Hudson et al., 2011b).
Also, Corynebacterium glutamicum employs the acyl pathway in
conjunction with the Ddh pathway (Schrumpf et al., 1991). A
search of the V. spinosum genome suggests that the DapL path-
way is the only route for diaminopimelate/lysine biosynthesis,
since orthologs of the acyl and dehydrogenase genes could not
be identiﬁed in the genome (Table 1; Figure 1). Even though
the search did not identify a diaminopimelate dehydrogenase
ortholog, we tested for dehydrogenase activity using the same
protein extract that was used to detect DapL activity. This test
was done using 1.0 mg of total protein in two different buffer
systems, ﬁnding no activity. The recombinant diaminopime-
late dehydrogenase from Clostridium thermocellum was used
as a positive control (Hudson et al., 2011b). This result was
FIGURE 2 | DapL activity from crude protein extract fromV. spinosum.
The graph shows the relationship between the protein amount and reaction
rate. The DapL ortho-aminobenzaldehyde assay is described in the Section
“Materials and Methods.”The assay was done in triplicates for each protein
concentration.
consistent with the genomic analysis regarding the absence of a
diaminopimelate dehydrogenase ortholog in the genome of V.
spinosum.
THE GENE ANNOTATED BY THE LOCUS TAG VspiD_010100012510
(VsdapL) ENCODES AN AUTHENTIC L,L-DIAMINOPIMELATE
AMINOTRANSFERASE
The putative VsdapL gene was cloned and the recombinant
enzyme was puriﬁed to homogeneity using afﬁnity chromatogra-
phy (Figure 3). The ortho-aminobenzaldehyde assay was used to
determinewhether the putativeVsDapLhadL,L-diaminopimelate
aminotransferase activity. The results from this analysis show that
the open reading frame annotated by the locus tag encodes an
authentic L,L-diaminopimelate aminotransferase enzyme. With
L,L-diaminopimelate as the amino donor and 2-ketoglutarate as
the amino acceptor, the speciﬁc activity of theVsDapL is 4.1± 0.25
ΔA440 min−1 mg−1. Unlike the plant and algae enzyme, VsDapL
possesses transamination activity with several diamine donors
that are structurally similar to L,L-diaminopimelate, including the
racemic isomer meso-diaminopimelate (Table 2), albeit at rela-
tively low rates. The enzyme is also able to use several oxoacids
as amino acceptors in addition to 2-ketoglutarate (Table 2); again
the relative rates are low.
VsdapL IS ABLE TO FUNCTIONALLY COMPLEMENT THE E. COLI
ΔdapD/dapE (AOH1) MUTANT
The E. coli strain AOH1 harbors a deletion of the dapD
gene and a mutation in dapE that renders this enzyme non-
functional (Hudson et al., 2006). As such, the mutant is unable
to synthesize meso-diaminopimelate for lysine and cell wall
biosynthesis. As a result, the cells lyse from osmotic pressure
due to the lack of meso-diaminopimelate as a cross linking
amino acid in the cell wall and is deemed auxotrophic for
diaminopimelate and lysine. For complementation analysis, E.
coli AOH1 was transformed with the empty vector (pBAD33),
or with the DapL expression vectors (pBAD33 + dapL) from
the plant Arabidopsis thaliana (AtdapL; Hudson et al., 2006),
the alga C. reinhardtii (CrdapL; Dobson et al., 2011) or the
bacterium V. spinosum (VsdapL). While E. coli AOH1 is able
to grow on media supplemented with L,L-diaminopimelate,
only the auxotrophic mutant expressing authentic orthologous
FIGURE 3 | Recombinant expression and purification ofVsDapL using
affinity chromatography. Lane (1) Protein Marker (kDa), Lane (2) 10μg of
soluble protein from uninduced cells, Lane (3) 10μg of soluble proteins
from induced cells, Lane (4) 1μg of puriﬁed VsDapL. The proteins were
resolved on a 10% (w/v) acrylamide gel and were stained with Coomassie
blue for visualization.
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DapLs are able to grow on L,L-diaminopimelate-free media
(Figure 4). This analysis demonstrates that the recombinant
enzymes are able to convert tetrahydrodipicolinate to L,L-
diaminopimelate,bypassing three acyl enzymatic reactions present
in the E. coli acyl pathway, to facilitate the synthesis of meso-
diaminopimelate for lysine and cell wall biosynthesis (Figures 1
and 5).
VsDapL BELONGS TO THE DAPL1 FORM OF L,L-DIAMINOPIMELATE
AMINOTRANSFERASES
Diaminopimelate aminotransferases are approximately 400 amino
acids in length and are members of the pyridoxal-5′phosphate
dependent family of class I/II transaminases. A recent study
revealed that there are two diverged forms of DapL enzymes;
DapL1 and DapL2 (Hudson et al., 2008). The two forms of
DapLs share approximately 30% homology on the amino acid
level. The DapL ortholog from C. trachomatis is evolutionar-
ily related to DapL1 enzymes (Hudson et al., 2008). Since the
homology of the V. spinosum DapL is only 38% to the C. tra-
chomatis ortholog, the form of the V. spinosum DapL was not
apparent. Using phylogenetic analysis, the DapL ortholog from
V. spinosum clusters with enzymes some of which have been
experimentally conﬁrmed as DapL1 orthologs and from patho-
genic organisms (Hudson et al., 2008, 2011b). The analysis shows
two distinct clades, DapL1, DapL2. The aspartate aminotrans-
ferase from Yersinia pseudotuberculosis, which is also classiﬁed
as a class I/II transaminase is used as an outgroup (Figure 6).
Four analyses were performed (ML, MP, ME, NJ) and all show
moderate to strong support the DapL2 clade (57–100%) and
for the DapL1 clade (56–99%). The more variable maximum
likelihood bootstrap support is alignment dependent with alter-
native alignments techniques (Clustal vs. MUSCLE) exhibiting
higher ML bootstrap values for the DapL1 and DapL2 clades
respectively. Muscle-aligned sequences generally exhibit higher
bootstrap support for both DapL1 and DapL2 clades than
Clustal.
VsmurE IS ABLE TO FUNCTIONALLY COMPLEMENT THE E. COLI murE
MUTANT
meso-Diaminopimelate serves not only as the penultimate pre-
cursor for lysine biosynthesis, but it is also incorporated as
one of the cross linking amino acids in the cell wall of Gram-
negative bacteria. This is facilitated by the enzyme UDP-N -
acetylmuramoylalanyl-D-glutamyl-2,6-meso-diaminopimelate lig-
ase (MurE; Figure 5). Since V. spinosum is classiﬁed as Gram-
negative bacterium, it should possess a MurE ortholog (Schlesner
et al., 2006). The VsmurE ortholog was identiﬁed and the open
reading frame was cloned into an expression vector to test via
functional complementationwhether the gene encodes an authen-
tic MurE enzyme. The E. coli mutant TKL-11 harbors a muta-
tion in the murE gene which results in a temperature sensitive
growth phenotype where the mutant is able to grow at the per-
missive temperature of 30˚C, but not at 42˚C (Lugtenberg and
van Schijndel-van Dam, 1972). The mutant was transformed with
an empty vector (pBAD33) and a vector expressing the puta-
tive MurE (pBAD33+VsmurE). Using replica-plating, the results
from this analysis demonstrate that at the permissive temperature
of 30˚C, the mutant harboring both the vector control and the vec-
tor expressing the recombinant enzyme are able to grow. However,
when exposed to the non-permissive temperature of 42˚C,only the
mutant expressing the MurE ortholog is able to grow (Figure 7A).
This result was corroborated by assessing bacterial growth over a
period of 10 h. At 30˚C the mutant harboring the vector only and
the murE expression vector grew as expected. However, when the
cultures were switched to the non-permissive temperature of 42˚C
after 5 h from 30˚C, only the mutant harboring the murE expres-
sion vector continued to grow. The optical density of the vector
only culture declined which can be attributed to rapid lysis of the
cell due to the lack of proper peptidoglycan synthesis (Figure 7B).
The assessment of crude soluble protein extracts from the com-
plementation experiment using SDS-PAGE analysis conﬁrmed the
expression of the recombinant MurE (59 kDa) in TKL-11 cells
harboring the expression vector (pBAD33+VsmurE) grown at
FIGURE 4 | Functional complementation of E. coli ΔdapD/dapE (AOH1) mutant.The AOH1 mutant harboring the plasmids pBAD33, pBAD33+AtdapL,
pBAD33+CrdapL, and pBAD33+VsdapL was replica-plated on LB medium supplemented with 0.2% (w/v) arabinose with or without 50μg/mL
L,L-diaminopimelate. For presentation purposes only one colony from the vector only and recombinant plasmids are represented in the diagram.
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FIGURE 5 | Schematic representation of the bacterial peptidoglycan
synthesis using m-DAP as one of the cross linking amino acids.The
cytosolic, membrane, and periplasmic steps are shown. The abbreviations of
the enzymes are as follows: MurA (UDP-N -acetylglucosamine enolpyruvyl
transferase), MurB (UDP-N -acetylenolpyruvoylglucosaminereductase), MurC
(UDP-N -acetylmuramate-L-alanine ligase), MurD (UDP-N -acetyl-
muramoylalanine-D-glutamate ligase), MurE (UDP-N -acetylmuramoyl-
L-alanyl-D-glutamate 2,6-meso-diaminopimelate ligase), MurF
(UDP-N -acetylmuramoyl-tripeptide-D-alanyl-d-alanine ligase), Ddl
(D-alanine-D-alanine ligase B), MraY (phospho-N -acetylmuramoyl-
pentapeptide-transferase), MurG (pyrophosphoryl-undecaprenol-
N -acetylglucosamine transferase), and PBPs (penicillin binding proteins).
42˚C that is not present in the extract from TKL-11 harboring the
vector only control (pBAD33) grown at 30˚C (Figure 7C).
THE AMINO ACIDS THAT CONSTITUTE THE ACTIVE SITE ARE
CONSERVED IN VsDapL
To examine more closely the VsDapL variant at the amino acid
level, we aligned its amino acid sequence to that of three DapL
orthologs already functionally and structurally characterized from
Arabidopsis thaliana (Watanabe et al., 2007), C. reinhardtii (Dob-
son et al., 2011), and C. trachomatis (Watanabe et al., 2011;
Figure 8). The VsDapL sequence has more similarity to the
CrDapL and AtDapL sequences, but like the CtDapL sequence,
has a truncated N-terminal region. The longer N-terminal regions
for the eukaryotic sequences is attributed to subcellular localiza-
tion sequences, used by A. thaliana and C. reinhardtii to target
the enzyme to the chloroplast, where lysine biosynthesis in known
to occur (Mills and Wilson, 1978). As can be seen in Figure 8
(residues in red bold), the putative active site residues are well
conserved between the four DapL enzymes. In addition, the loop
regions that form the active site cleft are generally well con-
served. In particular, loops A and C are well conserved, although
loop B shows more variability. From previous structural studies
(Watanabe et al., 2007, 2011; Dobson et al., 2011), it is known
that loop B is disordered and its role in catalysis is less clear.
However, noting the increased substrate promiscuity displayed by
VsDapL, it is possible that loop B may be involved in the substrate
binding step.
A homology model of the VsDapL was generated using the
Swiss-Model Protein Modeling Server (Figure 9). The tertiary
structure of the DapL monomer has been annotated as hav-
ing a large and a small domain, which also includes the arm
region (Figure 9A). Most aminotransferases are approximately
100 kDa in mass, representing a homodimeric quaternary struc-
ture. Assuming that the functional unit of the VsDapL enzyme is
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FIGURE 6 | Phylogenetic relationship of DapL amino acid sequences.
The VsDapL ortholog is annotated with a black circle. Minimum evolution
(ME) topology shown with maximum likelihood (ML), maximum
parsimony (MP), minimum evolution (ME), and neighbor-joining (NJ)
bootstrap values for both the DapL1 and DapL2 clades (from left to right).
Branch lengths are proportional to divergence; the scale below the tree
indicates percent divergence of the branch lengths. The tree was rooted
with a single outgroup aspartate aminotransferase (AspC) from
Y. pseudotuberculosis. Figure drawing produced using FigTree (ver. 1.6.1;
Rambaut, 2009).
a dimer, which is required for proper orientation of the conserved
active site residues within the active site, VsDapL probably has
two active sites (Figure 9B). Closer examination of one active site
(Figure 9C) highlights those residues that are conserved from the
multiple sequence alignment (Figure 8) and the key loop regions
that line the active site. Importantly, the model predicts that loop
B is positioned at the entrance of the active site cleft, ideally placed
to interact with substrates entering the active site.
DISCUSSION
The discovery of a new biosynthetic route to diaminopimelate
and lysine in plants, algae, and bacteria provides a fresh target for
the discovery of novel herbicides, algaecides, and antibiotics. The
amino acids that constitute the active site of DapL are conserved
in theV. spinosum ortholog based on protein alignment and mod-
eling. Therefore, inhibitors of CtDapL and AtDapL are likely to
inhibit VsDapL. To this end, V. spinosum is a suitable bacterial
system for the development of in vivo assays for the discovery of
compounds that are able to inhibit DapL to facilitate antibiotic
development.
Since V. spinosum can be genetically altered using exogenous
DNA, V. spinosum is an excellent candidate for determining the
essentiality of dapL via mutagenic experiments using transposon
and or homologous recombination. Moreover, the organism is
aerobic, relatively easy to culture and non-pathogenic to humans,
unlike other bacteria that contain the DapL pathway, such as Lep-
tospira interrogans,Bacteriodes fragilis, and C. trachomatis (McCoy
et al., 2006; Hudson et al., 2008).
Recently, our laboratories demonstrated that the orthologous
dapL from the model plant system Arabidopsis thaliana is essen-
tial for growth and development (Dobson et al., 2011). However,
it is not known if the same is true for bacteria that exclusively
utilize the DapL pathway for diaminopimelate/lysine synthesis. It
is not known whether another aminotransferase capable of inter-
converting tetrahydrodipicolinate and L,L-diaminopimelate exists
in bacteria that solely contain the DapL pathway. Thus, a suit-
able dapL bacterial mutant that is auxotrophic for diaminopime-
late/lysine would be an important step forward especially since
there are examples in the literature regarding substrate promis-
cuity of aminotransferases involved in amino acid metabolism.
For instance, the aspartate aminotransferase, tyrosine amino-
transferase, and the branched-chain amino acid aminotransferase
have been shown to possess overlapping activities in E. coli (Gu
et al., 1998). In addition, a recent study demonstrated that three
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FIGURE 7 | Functional complementation of the E.coli murE mutant.
(A)The E. coli mutant TKL-11 harboring pBAD33 or pBAD33+VsmurE. The
bacteria were grown to an OD of 0.1 at 600 nm and were serially diluted to
10−1, 10−2, and 10−3 using 0.85% (w/v) saline. The bacteria were
replica-plated on LB medium supplemented with 0.2% (w/v) arabinose. The
growth was assessed at 30 and 42˚C after 24 h. Only one colony from the
vector only and recombinant plasmid was used to create the diagram.
(B) Growth curve of E. coli TKL-11 harboring either the empty vector
pBAD33 (circles), or pBAD33+VsmurE (triangles). The cells were grown at
30˚C for 5 h then shifted to 42˚C for an additional ﬁve hours (shaded area).
(C) SDS-PAGE analysis of proteins extracted fromTKL-11 grown in LB
supplemented with 0.2% arabinose (w/v). Lane (1) protein ladder (kDa),
Lane (2) 10μg of soluble protein extract fromTKL-11 harboring pBAD33
grown at 30˚C, Lane (3) 10μg of soluble protein extract harboring
pBAD33+VsmurE grown at 42˚C. The proteins were resolved on a 10%
(w/v) acrylamide gel and were stained with Coomassie blue for
visualization.
aminotransferases are involved in alanine biosynthesis in E. coli
(Yoneyama et al., 2011).
Aminotransferases are common in the genome of V. spinosum
given their integral role in multiple anabolic and catabolic path-
ways. If a compound inhibits a bacterial DapL in vitro, as in the
case of the Arabidopsis enzyme, the question of whether this com-
pound is speciﬁc for DapL in vivo will have to be investigated.
One way to answer this question would be to use in vivo studies
by exposing the putative inhibitory compound to a dapL mutant
supplemented with diaminopimelate in the medium to observe
the growth phenotype. If the inhibitory compound is speciﬁc for
DapL, one would expect that it will not have any effect on the
mutant. However, the same compound should have an effect on
the wild-type parental strain used to create the dapL mutant. The
inhibition of DapL will prevent m-DAP production which would
lead to cell death caused by the lack of proper protein and cell wall
biosynthesis.
Here we present the elucidation of the biosynthetic pathway
of diaminopimelate/lysine from V. spinosum using genomic, bio-
chemical, and structural approaches. The enzymes involved in the
bacterial diaminopimelate/lysine biosynthetic pathways are pre-
sumed targets for antibiotic development. The identiﬁcation and
characterization of these enzymes provides valuable information
pertaining to experiments aiming to elucidate the essentiality of
genes involved in the bacterial diaminopimelate/lysine biosyn-
thesis pathways. The DapL pathway is the sole route toward
diaminopimelate/lysine inV. spinosum. In addition, the bacterium
can be genetically modiﬁed, the organism is relatively easy to cul-
ture and non-pathogenic to animals. These criteria make V. spin-
osum an excellent bacterial model for elucidating the essentiality
of genes involved in diaminopimelate/lysine metabolism.
MATERIALS AND METHODS
V. SPINOSUM GROWTH CONDITIONS
Theplasmids and strains used in this study are listed inTable 3. The
V. spinosum DSM 4136T organism was cultured in R2A medium
at 26˚C.
MULTIPLE-PROTEIN SEQUENCE ALIGNMENT, PHYLOGENETIC TREE
CONSTRUCTION, AND HOMOLOGY MODEL OF VsDapL
A DapL protein sequence alignment was generated using the
ClustalW server2. Phylogenetic trees were constructed from MUS-
CLE aligned amino acid sequences using maximum likelihood
(ML), maximum parsimony (MP) minimum evolution (ME),
and neighbor-joining (NJ) techniques in MEGA 5.05 (Tamura
et al., 2011). ML searches were performed using the likelihood-
based WAG (Whelan and Goldman, 2001) model of amino acid
character evolution, gamma distributed rates across sites, and
the proportion of invariant sites estimated from the data set
(WAG+G+ I). ME and NJ tree searches were performed using
the parsimony-based JTT model (Jones et al., 1992) and gamma
distributed rates (JTT+G). Optimal models were determined
by MEGA 5.05 that iteratively tests the partition against hierar-
chically nested models of evolution to obtain the best ﬁt. Node
strength was assessed using the bootstrap technique and 100
pseudo-replicate data sets for each analysis type (ML,MP,ME, and
NJ). The accessions numbers for the following DapL proteins are:
Arabidopsis thaliana (AEE86265), V. spinosum (ZP_02927470),
C. reinhardtii (XP_001693061), C. trachomatis (NP_219900),
Parachlamydia UWE25 (YP_007684), Synechocystis sp. PCC 6803
(BAA10583), Thermosynechococcus elongatus BP1 NP_682892),
Bacteroides fragilis NCTC 9343 (YP_212286), Clostridium
thermocellum 27405 (YP_001039489), Methanothermobacter
2http://www.ebi.ac.uk/Tools/msa/clustalw2/
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FIGURE 8 | Protein sequence alignment of DapL fromV. spinosum, C.
trachomatis, A. thaliana, and C. reinhardtii generated using the ClustalW
server (http://www.ebi.ac.uk/Tools/msa/clustalw2/). Putative active-site
residues, based on the structural studies of the ligand bound AtDapL and
CrDapL enzymes, are shown in red. The loop regions correspond to the key
loops that line the active site, where the asterisk refers to the loop
contributing to the active site of the opposing monomer. The ClustalW scores
relative to the V. spinosum sequence were: vs. C. reinhardtii =49
(length=443 residues, identity); vs. A. thaliana =45 (length=426 residues);
vs. C. trachomatis =39 (length=394 residues).
thermoautotrophicus (NP_275195), Geobacter sulfurreducens
(NP_951224), Leptospira interrogans (YP_002757), Nostoc
PCC 7120 (NP_488367), Gloeobacter violaceus PCC 7421
(NP_927054), Methanosaeta thermophila PT (YP_843230),
Methanospirillum hungatei JF1 (YP_504354), Dehalococcoides
CBDB1 (YP_307791), Methanococcoides burtonii DSM 6242
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FIGURE 9 |VsDapL homology model generated with the
Swiss-Model Protein Modeling Server (Arnold et al., 2006) using
the CrDapL apo structure as a template (PDB id: 3QGU Dobson
et al., 2011; Hudson et al., 2011a, BLAST identity=51% (207/404
residues), QMEAN4 score=0.673). (A)The domain structure of the
monomer. Note that, as seen in Figure 8, VsDapL has a truncated
N-terminal arm region compared to CrDapL and AtDapL. (B) Assuming
a dimeric structure, which is required to place the conserved active site
resides (highlighted in red bold Figure 8), the two active sites of the
dimer are shown. (C) A close up view of active site 1 showing the
conserved active site residues and the loops lining the active site (as
per Figure 8).
(YP_565702), Methanosarcina barkeri Fusaro (YP_306095),
Methanosarcina acetivorans C2A (NP_616639), Syntrophobac-
ter fumaroxidans MPOB (YP_844192), Planctomyces brasilien-
sis DSM 5305 (YP_004269630), Planctomyces limnophilus DSM
3776 (YP_003632005), Verrucomicrobiae bacterium DG1235
(ZP_05058547). The accession number for the Yersinia pseudo-
tuberculosis IP 32953 aspartate aminotransferase (AspC) is
(CAH20674).
A homology model of the VsDapL protein was generated using
the Swiss-Model Protein Modeling Server (Arnold et al., 2006)
using the CrDapL apo structure as a template (PDB id: 3QGU;
Dobson et al., 2011). The model was examined by hand for clashes
and appropriate geometry using the visualization software COOT
(Emsley and Cowtan, 2004).
PCR AMPLIFICATION AND CLONING OF THE V. SPINOSUM dapL AND
murE OPEN READING FRAMES
The full length ORFs annotated by the locus tags VspiD_0101000
12510 (dapL, L,L-diaminopimelate aminotransferase) and
VspiD_010100019130 (murE, UDP-N -acetylmuramoylalanyl-d-
glutamyl-2,6-meso-diaminopimelate ligase) were ampliﬁed by
PCR. The ORFs were ampliﬁed using: 12 pmol of forward and
reverse primers, 1 mM MgSO4, 0.5 mM of each of the four
deoxynucleotide triphosphates, 0.5 ng of genomic DNA and 1 unit
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Table 2 | Activity ofVsDapL with various amino donors and amino
acceptors.
Amino donor Relative
activity (%)
Amino acceptor Relative
activity (%)
L,L-diaminopimelate 100 2-Ketoglutarate 100
meso-Diaminopimelate 1.6±0.35 Pyruvate 8.1±0.3
L-Lysine 3.0±0.2 Oxaloacetate 7.4±0.15
L-Ornithine 5.1±0.2 Oxovalerate 7.9±0.15
The assay measures the production of dihydroquinazolium at 440 nm using
the ortho-aminobenzaldehyde assay. The assays pertaining to each amino
donor/acceptor combination was done in triplicates, the relative activity is based
on the activity of the enzyme with L,L-diaminopimelate and 2-ketoglutarate as
substrates.
of Platinum Pfx DNA polymerase (Invitrogen Corporation,Carls-
bad, CA, USA) using the following PCR conditions: 1 cycle at
94˚C for 2 min, followed by 30 cycles of 94˚C for 15 s, 60˚C for
30 s and 72˚C for 2 min. The forward and reverse primers used to
amplify the ORFs were VsdapL F and VsdapL R for the dapL ORF
and VsmurE F and VsmurE R for the murE ORF. The nucleotide
sequences of the primers are listed in Table 4. The underlined
sequence represents the restriction enzyme sites used to facilitate
cloningof theORFwhile thebolded and italicized sequences repre-
sent initiation and termination codons. For cloning, the dapL PCR
fragment was digested with EcoRI and SalI and ligated into the
plasmid pET30a (EMD Biosciences, Gibbstown, NJ, USA) to pro-
duce the plasmid pET30a+VsdapL. The murE PCR fragment was
ligated into the plasmid pET100D/topo (Invitrogen Corporation,
Carlsbad, CA, USA) to produce the plasmid pE100D+VsmurE.
The recombinant protein derived from this plasmid carries a hexa-
histidine tag derived from pET30a and pET100D plasmids at the
amino terminus. To conﬁrm the ﬁdelity of the PCR reactions, the
dapL ORF was sequenced from pET30a using the T7 promoter
and the T7 terminator primer (Table 4). The murE ORF was
sequenced from pET100D using the T7 promoter and T7 R primer
(Table 4). Both the dapL and murE ORFs are 100% identical to the
sequences deposited in the Integrated Microbial Genomes (IMG)
public database3.
FUNCTIONAL COMPLEMENTATION PLASMID CONSTRUCTS
The plasmids used for functional complementation of the E.
coli ΔdapD/dapE double mutant and the E. coli murE mutant
were produced by sub-cloning the XbaI and SalI fragment from
pET30a+VsdapL and the pET100D+VsmurE plasmids into
pBAD33 to produce pBAD33+VsdapL and pBAD33+VsmurE
(Guzman et al., 1995). The fusion proteins produced from the
pBAD33 constructs are identical to the proteins produced from
the pET30a and pET100D constructs.
FUNCTIONAL COMPLEMENTATION OF THE E. COLI dapD/E AND murE
MUTANTS
The E. coli mutant AOH1 (dapD::Kan2, dapE6) was trans-
formed with pBAD33 or plasmids harboring dapL orthologs
3http://img.jgi.doe.gov/cgi-bin/w/main.cgi
Table 3 | Plasmids and strains used in this study.
Plasmid/strains Vendor/Reference
pET30A Novagen, USA
pET100D/Topo Invitrogen, USA
pBAD33 Guzman et al. (1995)
pBAD33+AtdapL Hudson et al. (2006)
pBAD33+CrdapL Dobson et al. (2011)
pET30A+VsdapL This study
pET100D+VsmurE This study
pBAD33+VsdapL This study
pBAD33+VsmurE This study
Verrucomicrobium spinosum DSM 4136 Schlesner (1987)
5-alpha competent cells New England Biolabs, USA
BL21 codon plus RIPL Agilent Technologies, USA
AOH1 (ΔdapD/dapE ) Hudson et al. (2006)
TKL-11 (murE ) Lugtenberg and van
Schijndel-van Dam (1972)
Table 4 | List of Primers used for PCR amplification, cloning and
nucleotide sequencing.
Primer name Sequence (from 5′ to 3′)
VsdapL F CCCCGAATTCATGGCCCTCATCAACGAAAACTTCCTCAAG
VsdapL R CCCCGTCGACCTACTTCAGCGCGGCGATACGGCGGCAGAC
VsmurE F CACCATGACCATTTTGCGCGATCTTATCGAGGGT
VsmurE R GTCGACTCACTGACGGTCATCCCTCCTTTGGCGTGC
T7 promoter TAATACGACTCACTATAGGG
T7 R TAGTTATTGCTCAGCGGTGG
T7 terminator TATGCTAGTTATTGCTCAG
The underlined sequences represent restriction enzyme sites.The bolded and ital-
icized sequences are denoted as the start and stop codons for the open reading
frames (ORFs).
from V. spinosum (pBAD33+VsdapL), Arabidopsis thaliana
(pBAD33+AtdapL), and C. reinhardtii (pBAD33+CrdapL).
Transformants were selected on LB agar medium supplemented
with 50μg mL−1 DAP and 34μg mL−1 chloramphenicol. Ten
individual colonies from the vector only and the recombinant
plasmid were then replica-plated onto LB medium plus 0.2%
(w/v) arabinose with or without 50μg mL−1 DAP. The cultures
were grown at 30˚C for 24 h. The E. coli murE mutant (TKL-11)
(thr-1, leuB6 (Am), murE1, fhuA21, codA1, lacY1, tsx-95, glnV44
(AS), λ−, pyrF101, his-108, thyA6, argG66, ilvA634, thi-1, deoC1)
was transformed with pBAD33 or pBAD33+VsmurE (Table 3).
Transformants were selected on LB agar medium supplemented
with 50μg mL−1 thymine and 34μg mL−1 chloramphenicol at
30˚C. Ten individual colonies from the vector only and recombi-
nant plasmid transformationwere replica-plated onto LBmedium
plus 0.2% (w/v) arabinose and 50μg mL−1 thymine. The cul-
tures were grown at 30 and 42˚C for 24 h to assess functional
complementation.
PROTEIN EXPRESSION AND PURIFICATION OF VsDapL
The E. coli BL21-CodonPlus-RIPL strain was transformed with
the plasmid pET30a+VsdapL and grown in LB broth containing
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50μg mL−1 kanamycin and 34μg mL−1 chloramphenicol at 37˚C
to an OD600 of 0.5. Protein expression was induced in 1.0 L of
culture using isopropyl β-d-1-thiogalactopyranoside to a ﬁnal
concentration of 0.5 mM for 6 h at 20˚C. The cell pellet was lysed
by sonication in a solution of 50 mM sodium phosphate (pH 8.0)
and 300 mM NaCl. The soluble extract was incubated with 1 mL
bed volume of Talon Metal Afﬁnity Resin (Clontech, Mountain
View, CA, USA) for 30 min at 4˚C. The resin was washed ﬁve
times with 30 mL of sonication buffer containing 10 mM imi-
dazole (pH 8.0) for 15 min each. The enzyme was eluted with
10 mL of sonication buffer containing 250 mM imidazole (pH
8.0). The pure protein was concentrated in an Amicon Ultra
10,000 molecular weight cutoff ﬁlter unit replacing the elution
buffer with 100 mM HEPES-KOH containing 1 mM DTT, 2 mM
EDTA (pH 7.6). The recombinant protein was stored in 50%
glycerol. Protein concentration was measured using the Brad-
ford assay with bovine serum albumin as the standard (Bradford,
1976).
L,L-DIAMINOPIMELATE AMINOTRANSFERASE ENZYME
ORTHO-AMINOBENZALDEHYDE ASSAY
The ortho-aminobenzaldehyde assay measured the formation of
THDPA from L,L-DAP using ortho-aminobenzaldehyde, which
forms a dihydroquinazolium adduct with a maximum absorbance
at 440 nm. The assay contained 100 mM HEPES-KOH (pH 7.6),
0.5 mM amino donor, 2 mM amino acceptor and 1.25 mM ortho-
aminobenzaldehyde and 10.0μg of puriﬁed recombinantVsDapL
enzyme in a 0.5 mL reaction. The reactions were incubated at
30˚C and the change in absorbance was measured continuously
at 440 nm using a Beckman DU640 spectrophotometer.
MESO-DIAMINOPIMELATE DEHYDROGENASE ACTIVITY
Ddh activity was assessed using oxidative deamination. The assay
consisted of 0.5 mM m-DAP, 0.5 mM NADP+, and 1 mg of crude
soluble V. spinosum extract or 10μg of pure recombinant meso-
diaminopimelate dehydrogenase from C. thermocellum (Hudson
et al., 2011b) in 100 mM glycine-KOH (pH 10.5) or 100 mM
HEPES-KOH (pH 7.6) in a ﬁnal volume of 0.5 mL. The produc-
tion of NADPH was measured continuously at 340 nm at 30˚C
using a Beckman DU640 spectrophotometer
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